Citation Impact
Citing Papers
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
1996
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
1986
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
1987
Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.
1981
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
2009
Gastric cancer
2016 Standout
Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy
1968
Pharmacokinetic Study of Omeprazole in Elderly Healthy Volunteers
1992
Long-Term Results of a Randomized Prospective Study Comparing Medical and Surgical Treatment of Barrett’s Esophagus
2003
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
1990 Standout
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy
2000
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
1988
Management of Crohn's disease in adults
2001
High Incidence and Prevalence of Adult Coeliac Disease Augmented Diagnostic Approach
1997
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
2000
Sjögren's syndrome
2005 Standout
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
The Intriguing Relationship of <i>Helicobacter pylori</i> Infection and Acid Secretion in Peptic Ulcer Disease and Gastric Cancer
2011
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique
2005
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Influence of context effects on health outcomes: a systematic review
2001 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24‐Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal Injury
1991 Standout
New Data on Healing of Nonsteroidal Anti-inflammatory Drug–Associated Ulcers and Erosions
1998
Omeprazole and sucralfate in the treatment of NSAID‐induced gastric and duodenal ulcer
1998
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury
1996
Treatment of NSAID‐induced gastrointestinal lesions with cimetidine: an international multicentre collaborative study
1988
False Negative Urea Breath Tests with H2‐Receptor Antagonists: Interactions Between Helicobacter pylori Density and pH
2004
Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?
2000
Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter Study
1988
Medical Treatment of Peptic Ulcer Disease
1991
The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer
1999
Dyspepsia management in primary care: A decision analysis of competing strategies
2002
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
1988
Incidence and Prevalence of Adult Coeliac Disease within a Defined Geographic Area in Denmark
1996
Celiac Disease
2007 Standout
Helicobacter pylori and reflux disease
2003
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth
2001
Accuracy of Monoclonal Stool Antigen Test for the Diagnosis ofH. pyloriInfection: A Systematic Review and Meta-Analysis
2006
Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
1998
A Controlled Study of Ranitidine for the Prevention of Recurrent Hemorrhage from Duodenal Ulcer
1994
The Long‐term Impact of Helicobacter pylori Eradication on Gastric Histology: a Systematic Review and Meta‐analysis
2007
The Changing Epidemiology of Gerd: Geography and Helicobacter Pylori
2003
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Omeprazole ameliorates aspirin-induced gastroduodenal injury
1994
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Control of Gastric Acid Secretion in Health and Disease
2008
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease
2001
Helicobacter pylori: host genetics and disease outcomes
2008
Nonsteroidal Anti-inflammatory Drugs and Peptic Ulcer Disease
1991
Oesophageal carcinoma
2013 Standout
A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
1998
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
1987 Standout
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract the double-edged sword
1995
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion
2003
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori
2010
Stool antigen assay (HpSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection
2002
Acid suppression and gastri atrophy: sifting fact from fiction
1998
Review article: Helicobacter pylori eradication for the prevention of gastric cancer
2007
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
1999
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance Strategies
2007
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Breast-Feeding Protects Against Celiac Disease in Childhood — Epidemiological Evidence
2002
Evidence of poor vitamin status in coeliac patients on a gluten‐free diet for 10 years
2002
Gastric cancer
2020 Standout
Helicobacter pyloriInfection
2002 Standout
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis
2003
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
An analysis of 8305 cases of carcinoid tumors
2000 Standout
A guideline for the treatment and prevention of NSAID-induced ulcers
1998
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
The Swedish epidemic of coeliac disease explored using an epidemiological approach—some lessons to be learnt
2005
Bleeding Peptic Ulcer
1994 Standout
The health economics of Helicobacter pylori infection
2007
Early events in proton pump inhibitor‐associated exacerbation of corpus gastritis
2003
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
1998
Placebo effect in the treatment of duodenal ulcer
1999
Potential adverse effects of proton pump inhibitors
2008
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
COX-2 inhibitors
1999 Standout
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Chemoprevention of Oesophageal Cancer and the AspECT Trial
2008
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil
2011
Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric Lesions
2006
PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI
1988
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis
2006
Radioimmunoassay in Gastroenterology
1972 StandoutNobel
A Controlled Study Comparing the Effects of Nabumetone, Ibuprofen, and Ibuprofen Plus Misoprostol on the Upper Gastrointestinal Tract Mucosa
1993
Rapid Loss of Motility of Helicobacter pylori in the Gastric Lumen In Vivo
2005
Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.
1995
Structural Basis for Gluten Intolerance in Celiac Sprue
2002 StandoutScience
Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease
2006 StandoutNobel
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
1984
DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATE
1981
Further Studies on the Nature of Immunoreactive Gastrin in Human Plasma
1971 StandoutNobel
Coeliac disease
1997
The pathobiology of the human enterochromaffin-like cell.
1994
Regional Differences in Coeliac Disease Prevalence in Scandinavia?
1999
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
2007
Plasma Gastrin and Gastric Acid Responses to Sham Feeding and Feeding in Dogs
1972 StandoutNobel
Peptic Ulcer Disease
2011
Cimetidine for Severe Gastroduodenal Haemorrhage: A Randomized Controlled Trial
1980
DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS
1987
Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn?
2009
Creatinine Clearance: A Redundant Clinical Investigation
1986
Management of Peptic Ulcers: Emerging Issues
2000
A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden
1982
The Effect of Atropine on Plasma Gastrin Response to Feeding
1971 StandoutNobel
EFFECTS IN MAN OF HISTAMINE H2-RECEPTOR BLOCKADE BY BURIMAMIDE
1972 StandoutNobel
Effect of Glucagon on Meal-Induced Gastric Secretion in Man
1975
Nonsteroidal Anti-Inflammatory Drug Gastropathy
1996
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Effect of cimetidine on the gastric bacterial flora.
1980
Effect of Growth Hormone Release-Inhibiting Hormone on Gastric Secretion, Mucosal Blood Flow, and Serum Gastrin
1976 StandoutNobel
Canadian Helicobacter Study Group Consensus Conference: Update on the Approach to Helicobacter Pylori Infection in Children and Adolescents – an Evidence-Based Evaluation
2005
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer
2007
Postoperative Treatment with Corticosteroids and Salazosulphapyridine (SalazopyrinR) after Radical Resection for Crohn’s Disease
1976
Sulphur-methylene isosterism in the developent of metiamide, a new histamine H2-receptor antagonist
1974 StandoutNatureNobel
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
National Cooperative Crohn's Disease Study: Results of drug treatment
1979
UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
1984 Standout
Sulfasalazine
1983
Complexity and contradiction in clinical trial research
1987
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of A. Walan being referenced
Similar prevalence of coeliac disease in children and middle-aged adults in a district of Sweden.
1983
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
1998
Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trial
2006
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial
2003
Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
1989
Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression
2000
Safety Experience from Long-Term Treatment with Omeprazole
1992
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
2000
Pathophysiological effects of long-term acid suppression in man
1995
Antacids and Anticholinergics in the Treatment of Duodenal Ulcer
1984
Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
1999
Pharmacokinetics of [14C] omeprazole in patients with impaired renal function
1986
On the Prevalence of Adult Coeliac Disease in Sweden
1981
Inhibition of Pentagastrin-induced Gastric Acid Secretion in Man by Glucagon Given Intravenously
1969
MAINTENANCE TREATMENT OF RECURRENT PEPTIC ULCER BY CIMETIDINE
1978
Maintenance Treatment with Cimetidine in Peptic Ulcer Disease for Up to 4 Years
1987
The Effects of Cimetidine (Tagamet®) on Renal Function in Patients with Renal Failure
1980
The Effect of 1-Hyoscyamine on Pentagastrin-induced Secretion of Acid and Pepsin in Man
1970
The Effect of 20 Mg Omeprazole Daily on Serum Gastrin, 24-H Intragastric Acidity, and Bile Acid Concentration in Duodenal Ulcer Patients
1987
Effect of Cimetidine and Oxmetidine on 24-h Gastric Acid and Pepsin in Patients
1983
Reversal of Psychopathology in Adult Coeliac Disease with the Aid of Pyridoxine (Vitamin B6)
1983
Treatment of active prepyloric and duodenal ulcers with antacid/anticholinergic, cimetidine and placebo.
1982
Antacid/Anticholinergic, Cimetidine, and Placebo in Treatment of Active Peptic Ulcers
1981
The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study.
1974
The Effect of 1‐hyoscyamine in Tablets with Sustained Release on Gastric Secretion of Acid in Man
1965
CIMETIDINE IN THE TREATMENT OF ACTIVE DUODENAL AND PREPYLORIC ULCERS
1976
The Clinical Effect of Salazosulphapyridine (SalazopyrinR) in Crohn’s Disease
1974
Effect of Omeprazole, a Substituted Benzimidazole, on 24-H Intragastric Acidity in Patients with Peptic Ulcer Disease
1984
A Comparison of Two Different Doses of Omeprazole Versus Ranitidine in Treatment of Duodenal Ulcers
1986
Clinical Perspectives of Drugs Inhibiting Acid Secretion-H+K+-ATPase Inhibitors
1986
Steady-state Kinetics and Dosage Requirements of Cimetidine in Renal Failure
1981
Metabolic consequences of reduced gastric acidity
1985
Effect of 1-hyoscyamine on gastric secretion of acid and intrinsic factor in man.
1967
[Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].
1974
Guidelines for clinical trials in Helicobacter pylori infection
1997